Hydrocephalus clinical trials at University of California Health
2 research studies open to eligible people
open to eligible people ages 60 years and up
The Placebo-Controlled Efficacy in Idiopathic Normal Pressure Hydrocephalus (iNPH) Shunting (PENS) trial is a multi-center blinded, randomized, placebo-controlled design investigation of cerebrospinal fluid (CSF) shunt surgery to study the shunt efficacy in iNPH patients.
at UC Davis
open to all eligible people
This study evaluates the performance of a non-invasive thermal measurement device for assessing CSF shunt flow. Patients with an existing implanted shunt and symptoms of shunt malfunction will be evaluated with the study device.
Our lead scientists for Hydrocephalus research studies include Kiarash Shahlaie, MD, PhD, FAANS.